Novel targets for immunotherapy in glomerulonephritis

References

• AbeKMiyazakiMKojiT2001Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridizationKidney Int601374611422745
   PubMed Web of Science ®Google Scholar
• AbrahamsonDRPrettymanACRobertB2003Laminin-1 reexpression in Alport mouse glomerular basement membranesKidney Int638263412631063
   PubMed Web of Science ®Google Scholar
• AitmanTJDongRVyseTJ2006Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humansNature439851516482158
   PubMed Web of Science ®Google Scholar
• Alarcon-SegoviaDTumlinJAFurieRA2003LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled studyArthritis Rheum484425412571854
   PubMed Web of Science ®Google Scholar
• AmitalHHeilweilMUlmanskyR2005Treatment with a laminin-derived peptide suppresses lupus nephritisJ Immunol17555162316210660
   PubMed Web of Science ®Google Scholar
• AmitalHHeilweil-HarelMUlmanskyR2007Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorptionRheumatology (Oxford)461433717686790
   PubMed Web of Science ®Google Scholar
• AppelGNachmanPHoganS2002Eculizumab (C5 complement inhibitor) in the treatment of idiopathic membranous nephropathy (IMN): Preliminary baseline and pharmacokinetic (PK)/Pharmacodynamic (PD) dataJ Am Soc Nephrol13668A11856770
   PubMed Web of Science ®Google Scholar
• BaoLHaasMBoackleSA2002Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr miceJ Immunol1683601711907125
   PubMed Web of Science ®Google Scholar
• BaoLHaasMKrausDM2003Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr miceJ Am Soc Nephrol14670912595503
   PubMed Web of Science ®Google Scholar
• BaoLOsaweIPuriT2005C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonistEur J Immunol35249650616052609
   PubMed Web of Science ®Google Scholar
• BollandSRavetchJ2000Spontaneous autoimmune disease in Fcgamma. RIIB-deficient mice results from strain-specific epistasisImmunity132778510981970
   PubMed Web of Science ®Google Scholar
• BorzaDBondarOToddP2002Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domainsJ Biol Chem277400758312193605
   PubMed Web of Science ®Google Scholar
• BorzaDBBondarOColonS2005Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesisJ Biol Chem280271475415917228
   PubMed Web of Science ®Google Scholar
• BorzaDBHudsonBG2003Molecular characterization of the target antigens of anti-glomerular basement membrane antibody diseaseSpringer Semin Immunopathol243456112778332
   PubMed Web of Science ®Google Scholar
• BorzaDBNetzerKOLeinonenA2000The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3 (IV) collagen chainJ Biol Chem2756030710681598
   PubMed Web of Science ®Google Scholar
• BottoMDell’AgnolaCBygraveAE1998Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodiesNat Genet195699590289
   PubMed Web of Science ®Google Scholar
• BoutaudAAKalluriRKahsaiTZ1996Goodpasture syndrome: selective removal of anti-alpha 3 (IV) collagen autoantibodies. A potential therapeutic alternative to plasmapheresisExp Nephrol4205128864724
   PubMedGoogle Scholar
• BraunMDavisAE3rd1998Cultured human glomerular mesangial cells express the C5a receptorKidney Int54154299844130
   PubMedGoogle Scholar
• BrigantiEMRussGRMcNeilJJ2002Risk of renal allograft loss from recurrent glomerulonephritisN Engl J Med347103912110738
   PubMed Web of Science ®Google Scholar
• ChenZKoralovSBKelsoeG2000Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2J Exp Med19213395211067882
   PubMed Web of Science ®Google Scholar
• ClynesRDumitruCRavetchJV1998Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritisScience279105249461440
   PubMed Web of Science ®Google Scholar
• CoreshJSelvinEStevensLA2007Prevalence of chronic kidney disease in the United StatesJAMA29820384717986697
   PubMed Web of Science ®Google Scholar
• CouserWG1999GlomerulonephritisLancet35315091510232333
   PubMed Web of Science ®Google Scholar
• CouserW2005Recurrent glomerulonephritis in the renal allograft: an update of selected areasExp Clin Transplant3283815989671
   PubMedGoogle Scholar
• CouserWSteinmullerDStilmantM1978Experimental glomerulonephritis in the isolated perfused rat kidneyJ Clin Invest62127587372233
   PubMed Web of Science ®Google Scholar
• CouserWGNangakuM2006Cellular and molecular biology of membranous nephropathyJ Nephrol1969970517173240
   PubMed Web of Science ®Google Scholar
• CybulskyAVQuiggRJSalantDJ2005Experimental membranous nephropathy reduxAm J Physiol Renal Physiol289F6607116159900
   PubMed Web of Science ®Google Scholar
• CybulskyARennkeHFeintzeigI1986Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathyJ. Clin Invest7710961073514672
   PubMed Web of Science ®Google Scholar
• DavidMBorzaDLeinonenA2001Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitopeJ Biol Chem2766370711098057
   PubMed Web of Science ®Google Scholar
• DebiecHGuigonisVMougenotB2002Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodiesN Engl J Med34620536012087141
   PubMed Web of Science ®Google Scholar
• DebiecHNautaJCouletF2004Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathiesLancet3641252915464186
   PubMed Web of Science ®Google Scholar
• DebiecHRoncoP2007Fetomaternal alloimmunization with antenatal glomerulopathiesAnn N Y Acad Sci11105596617911472
   PubMed Web of Science ®Google Scholar
• DirksJHde ZeeuwDAgarwalSK2005Prevention of chronic kidney and vascular disease: toward global health equity – the Bellagio 2004 DeclarationKidney Int SupplS16
   Web of Science ®Google Scholar
• DonauerJWilpertJGeyerM2006ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experienceXenotransplantation131081016623802
   PubMed Web of Science ®Google Scholar
• Dragon-DureyMAFremeaux-BacchiVLoiratC2004Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 casesJ Am Soc Nephrol157879514978182
   PubMed Web of Science ®Google Scholar
• EinavSPozdnyakovaOOMaM2002Complement C4 is protective for lupus disease independent of C3J Immunol16810364111801636
   PubMed Web of Science ®Google Scholar
• ElliottMKJarmiTRuizP2004Effects of complement factor D deficiency on the renal disease of MRL/lpr miceKidney Int651293814675043
   PubMed Web of Science ®Google Scholar
• FanciulliMNorsworthyPJPetrettoE2007FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunityNat Genet39721317529978
   PubMed Web of Science ®Google Scholar
• FarquharMGSaitoAKerjaschkiD1995The Heymann nephritis antigenic complex: megalin (gp330) and RAPJ Am Soc Nephrol635477579068
   PubMed Web of Science ®Google Scholar
• FlotoRAClatworthyMRHeilbronnKR2005Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid raftsNat Med111056816170323
   PubMed Web of Science ®Google Scholar
• FosterMH2007T cells and B cells in lupus nephritisSemin Nephrol27475817336688
   PubMed Web of Science ®Google Scholar
• FujiiTHamanoYUedaS2003Predominant role of FcgammaRIII in the induction of accelerated nephrotoxic glomerulonephritisKidney Int6414061612969160
   PubMed Web of Science ®Google Scholar
• FurieR2006Abetimus sodium (riquent) for the prevention of nephritic flares in patients with systemic lupus erythematosusRheum Dis Clin North Am321495616504827
   PubMed Web of Science ®Google Scholar
• GasqueP2004Complement: a unique innate immune sensor for danger signalsMol Immunol4110899815476920
   PubMed Web of Science ®Google Scholar
• HahnBSinghRLa CavaA2005Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressorsJ Immunol17577283716301683
   PubMed Web of Science ®Google Scholar
• HahnBHSinghRRWongWK2001Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupusArthritis Rheum444324111229475
   PubMed Web of Science ®Google Scholar
• HeCImaiMSongH2005Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9J Immunol1745750715843577
   PubMed Web of Science ®Google Scholar
• HellmarkTBurkhardtHWieslanderJ1999Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodiesJ Biol Chem27425862810464328
   PubMed Web of Science ®Google Scholar
• HogasenKJansenJHMollnesTE1995Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiencyJ Clin Invest951054617883953
   PubMed Web of Science ®Google Scholar
• Huber-LangMSarmaJVZetouneFS2006Generation of C5a in the absence of C3: a new complement activation pathwayNat Med12682716715088
   PubMed Web of Science ®Google Scholar
• HudsonBGTryggvasonKSundaramoorthyM2003Alport’s syndrome, Goodpasture’s syndrome, and type IV collagenN Engl J Med34825435612815141
   PubMed Web of Science ®Google Scholar
• JansenJHHogasenKHarboeM1998In situ complement activation in porcine membranoproliferative glomerulonephritis type IIKidney Int53331499461093
   PubMed Web of Science ®Google Scholar
• JavaidBQuiggRJ2005Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics?Kidney Int67169270315840015
   PubMed Web of Science ®Google Scholar
• KalluriRCantleyLKerjaschkiD2000aReactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture syndromeJ Biol Chem275200273210748075
   PubMed Web of Science ®Google Scholar
• KalluriRDanoffTMOkadaH1997Susceptibility to anti-glomerular basement membrane disease and Goodpasture Syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in miceJ Clin Invest1002263759410904
   PubMed Web of Science ®Google Scholar
• KalluriRTorreAShieldCF3rd2000bIdentification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodiesTransplantation696798310708133
   PubMed Web of Science ®Google Scholar
• KanekoYNimmerjahnFMadaioMP2006aPathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptorsJ Exp Med2037899716520389
   PubMed Web of Science ®Google Scholar
• KanekoYNimmerjahnFRavetchJV2006bAnti-inflammatory activity of immunoglobulin G resulting from Fc sialylationScience313670316888140
   PubMed Web of Science ®Google Scholar
• KangHKMichaelsMABernerBR2005Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsetsJ Immunol17432475515749855
   PubMed Web of Science ®Google Scholar
• KerjaschkiDFarquharM1982The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush borderProc Natl Acad Sci USA795557616752952
   PubMed Web of Science ®Google Scholar
• KerjaschkiDHorvatRBinderS1987Identification of a 400-kd protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritisAm J Pathol129183912444109
   PubMed Web of Science ®Google Scholar
• KonoHKyogokuCSuzukiT2005FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signalingHum Mol Genet1428819216115811
   PubMed Web of Science ®Google Scholar
• La CavaAEblingFMHahnBH2004Ig-reactive CD4+CD25+ T cells from tolerized New Zealand Black x New Zealand White.F1 mice suppress in vitro production of antibodies to DNAJ Immunol1733542815322219
   PubMed Web of Science ®Google Scholar
• La CavaAFangCJSinghRP2005Manipulation of immune regulation in systemic lupus erythematosusAutoimmun Rev4515916214088
   PubMed Web of Science ®Google Scholar
• LeenaertsPLHallBMvan DammeBJ1995Active Heymann nephritis in complement component C6 deficient ratsKidney Int47160416147643529
   PubMed Web of Science ®Google Scholar
• LinFSalantDJMeyersonH2004Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritisJ Immunol17226364214764738
   PubMed Web of Science ®Google Scholar
• MackayMStanevskyAWangT2006Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLEJ Exp Med20321576416923849
   PubMed Web of Science ®Google Scholar
• McCoyRCJohnsonHKStoneWJ1982Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritisKidney Int21642527047864
   PubMed Web of Science ®Google Scholar
• McGahaTLSorrentinoBRavetchJV2005Restoration of tolerance in lupus by targeted inhibitory receptor expressionScience307590315681388
   PubMed Web of Science ®Google Scholar
• MeriSKoistinenVMiettinenA1992Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritisJ Exp Med175939501532415
   PubMed Web of Science ®Google Scholar
• MeyersKEKinniryPAKalluriR1998Human Goodpasture anti-alpha3 (IV)NC1 autoantibodies share structural determinantsKidney Int5340279461099
   PubMed Web of Science ®Google Scholar
• MitchellDAPickeringMCWarrenJ2002C1q deficiency and autoimmunity: the effects of genetic background on disease expressionJ Immunol16825384311859149
   PubMed Web of Science ®Google Scholar
• MiwaTZhouLTudoranR2007DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activityMol Immunol441394616887189
   PubMed Web of Science ®Google Scholar
• MorganBPHarrisCL2003Complement therapeutics; history and current progressMol Immunol401597012914822
   PubMed Web of Science ®Google Scholar
• NakamuraAYuasaTUjikeA2000Fcgamma receptor IIB-deficient mice develop Goodpasture’s syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane diseaseJ Exp Med19189990610704470
   PubMed Web of Science ®Google Scholar
• NetzerKOLeinonenABoutaudA1999The goodpasture auto-antigen. Mapping the major conformational epitope(s) of alpha3 (IV) collagen to residues 17–31 and 127–141 of the NC1 domainJ Biol Chem274112677410196215
   PubMed Web of Science ®Google Scholar
• NimmerjahnFBruhnsPHoriuchiK2005FcgammaRIV: a novel FcR with distinct IgG subclass specificityImmunity23415116039578
   PubMed Web of Science ®Google Scholar
• NimmerjahnFRavetchJV2005Divergent immunoglobulin g subclass activity through selective Fc receptor bindingScience3101510216322460
   PubMed Web of Science ®Google Scholar
• NimmerjahnFRavetchJ2006Fcgamma receptors: old friends and new family membersImmunity24192816413920
   PubMed Web of Science ®Google Scholar
• NimmerjahnFRavetchJV2007Fc-receptors as regulators of immunityAdv Immunol9617920417981207
   PubMed Web of Science ®Google Scholar
• OlsonDLAnandSKLandingBH1980Diagnosis of hereditary nephritis by failure of glomeruli to bind anti-glomerular basement membrane antibodiesJ Pediatr9669797359277
   PubMed Web of Science ®Google Scholar
• ParkSYUedaSHamanoY1998Resistance of Fc receptor-deficient mice to fatal glomerulonephritisJ Clin Invest541229389739057
   PubMed Web of Science ®Google Scholar
• PaulEPozdnyakovaOOMitchellE2002Anti-DNA autoreactivity in C4-deficient miceEur J Immunol322672912207352
   PubMed Web of Science ®Google Scholar
• PickeringMCCookHTWarrenJ2002Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor HNat Genet31424812091909
   PubMed Web of Science ®Google Scholar
• PickeringMCWarrenJRoseKL2006Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient miceProc Natl Acad Sci USA10396495416769899
   PubMed Web of Science ®Google Scholar
• PonticelliC2007Membranous nephropathyJ Nephrol202688717557260
   PubMed Web of Science ®Google Scholar
• ProdeusAPGoergSShenLM1998A critical role for complement in maintenance of self-toleranceImmunity9721319846493
   PubMed Web of Science ®Google Scholar
• RadekeHHGessnerJEUciechowskiP1994Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chainJ Immunol1531281928027555
   PubMed Web of Science ®Google Scholar
• RavetchJVBollandS2001IgG Fc receptorsAnnu Rev Immunol192759011244038
   PubMed Web of Science ®Google Scholar
• ReynoldsJProdromidiEIJuggapahJK2005Nasal administration of recombinant rat alpha3 (IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY ratJ Am Soc Nephrol161350915814836
   PubMed Web of Science ®Google Scholar
• ReynoldsJPuseyCD2001Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY ratJ Am Soc Nephrol12617011134251
   PubMed Web of Science ®Google Scholar
• RicklinDLambrisJD2007Complement-targeted therapeuticsNat Biotechnol2512657517989689
   PubMed Web of Science ®Google Scholar
• RiemekastenGLangnickeLDEnghardP2004Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cellsJ Immunol17358354215494537
   PubMed Web of Science ®Google Scholar
• RoncoPAllegriLBriantiE1989Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathologyAppl Pathol785982567175
   PubMedGoogle Scholar
• RoncoPMArdaillouNVerroustP1994Pathophysiology of the podocyte: a target and a major player in glomerulonephritisAdv Nephrol Necker Hosp23911318154367
   PubMedGoogle Scholar
• RoncoPDebiecH2007Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and menSemin Immunopathol294455817899086
   PubMed Web of Science ®Google Scholar
• RoozendaalRCarrollMC2007Complement receptors CD21 and CD35 in humoral immunityImmunol Rev21915716617850488
   PubMed Web of Science ®Google Scholar
• RudolphEHCongdonKLSackeyFN2002Humoral autoimmunity to basement membrane antigens is regulated in C57BL/6 and MRL/MpJ mice transgenic for anti-laminin Ig receptorsJ Immunol16859435312023401
   PubMed Web of Science ®Google Scholar
• SaitoAPietromonacoSLooAK1994Complete cloning and sequencing of rat gp330/“megalin”, a distinctive member of the low density lipoprotein receptor gene familyProc Natl Acad Sci, USA91972597937880
   PubMed Web of Science ®Google Scholar
• SausJWieslanderJLangeveldJ1988Identification of the Good-pasture antigen as the alpha 3(IV) chain of collagen IVJ Biol Chem26313374803417661
   PubMed Web of Science ®Google Scholar
• SchulzeMDonadioJVPruchnoCJ1991Elevated urinary excretion of the C5b-9 complex in membranous nephropathyKidney Int4053381787650
   PubMed Web of Science ®Google Scholar
• SchwartingA2006Genetic predisposition – is lupus nephritis a question of copy numbers?Nephrol Dial Transplant212378916864599
   PubMed Web of Science ®Google Scholar
• SekineHReillyCMMolanoID2001Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr miceJ Immunol16664445111342671
   PubMed Web of Science ®Google Scholar
• SheerinNSSpringallTAbeK2001Protection and injury: the differing roles of complement in the development of glomerular injuryEur J Immunol3112556011298352
   PubMed Web of Science ®Google Scholar
• SheerinNSSpringallTCarrollMC1997Protection against anti-glomerular basement membrane GBM-mediated nephritis in C3- and C4-deficient miceClin Exp Immunol11040399409643
   PubMed Web of Science ®Google Scholar
• SmithRJAlexanderJBarlowPN2007New approaches to the treatment of dense deposit diseaseJ Am Soc Nephrol1824475617675665
   PubMed Web of Science ®Google Scholar
• SongHHeCKnaakC2003Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activationJ Clin Invest11118758512813023
   PubMed Web of Science ®Google Scholar
• StollMLPriceKDSilvinCJ2007Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the SWR x NZB.F1 murine modelJ Autoimmun2930717459659
   PubMed Web of Science ®Google Scholar
• SusaniMSchulzeMExnerM1994Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritisAm J Pathol144807198160779
   PubMed Web of Science ®Google Scholar
• TarziRMDaviesKARobsonMG2002Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cellsKidney Int6220879612427132
   PubMed Web of Science ®Google Scholar
• TimoshankoJRTippingPG2005Resident kidney cells and their involvement in glomerulonephritisCurr Drug Targets Inflamm Allergy43536216101545
   PubMedGoogle Scholar
• ToubiEKesselAShoenfeldY2005High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosusHum Immunol6639540215866703
   PubMed Web of Science ®Google Scholar
• TurnbergDBottoMWarrenJ2003CD59a deficiency exacerbates accelerated nephrotoxic nephritis in miceJ Am Soc Nephrol142271912937303
   PubMed Web of Science ®Google Scholar
• TurnbergDCookHT2005Complement and glomerulonephritis: new insightsCurr Opin Nephrol Hypertens14223815821414
   PubMed Web of Science ®Google Scholar
• US Renal Data System2007ESRD incidence and prevalenceIn USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United StatesNational Institutes of Health, National Institute of Diabetes and Digestive and Kidney DiseasesBethesda, MD8198
   Google Scholar
• van DammeBFleurenGBakkerW1978Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritisLab Invest3850210147961
   PubMed Web of Science ®Google Scholar
• WakayamaHHasegawaYKawabeT2000Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient miceEur J Immunol3011829010760808
   PubMed Web of Science ®Google Scholar
• WangXPFogoABColonS2005Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3 (IV) collagen: a janus-faced antigenJ Am Soc Nephrol1635637116236801
   PubMed Web of Science ®Google Scholar
• WangYHuQMadriJA1996Amelioration of lupus-like auto-immune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5Proc Natl Acad Sci USA93856388710910
   PubMed Web of Science ®Google Scholar
• WatanabeHGarnierGCircoloA2000Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor BJ Immunol157869410623824
   PubMed Web of Science ®Google Scholar
• WieslanderJBarrJFButkowskiRJ1984Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagenProc Natl Acad Sci USA813838426328527
   PubMed Web of Science ®Google Scholar
• WilsonCB1997Immune Models of Glomerular InjuryNeilsonEGCouserWGImmunologic Renal DiseasesPhiladelphiaLippincott-Raven
   Google Scholar
• WolfraimLA2006Treating autoimmune diseases through restoration of antigen-specific immune toleranceArch Immunol Ther Exp (Warsz)5411316642252
   PubMed Web of Science ®Google Scholar
• WuHYWardFJStainesNA2002Histone peptide-induced nasal tolerance: suppression of murine lupusJ Immunol16911263412097422
   PubMed Web of Science ®Google Scholar
• ZhangYSCSuDBHecox2006Anti-Goodpasture autoantibodies escape regulation in a novel Ig transgenic modelJ Am Soc Nephrol1786 abst
   Google Scholar
• ZipfelPFHeinenSJozsiM2006Complement and diseases: defective alternative pathway control results in kidney and eye diseasesMol Immunol439710616026839
   PubMed Web of Science ®Google Scholar